Sylogist Announces Renewal of its NCIB and Declares Quarterly Dividend

Executive Summary

• The Toronto Stock Exchange approved Sylogist Ltd.’s Notice of Intention to commence a Normal Course Issuer Bid (NCIB) effective February 19, 2026, allowing the company to repurchase up to 2,258,992 common shares (10% of public float).
• Under the NCIB, daily purchase limits are set at 16,609 shares (25% of average daily trading volume over the prior six months). Shares will be bought on open market and cancelled; the program may terminate by February 18, 2027 or earlier if purchase limits are met.
• The Board also declared a cash dividend of $0.01 per share payable on March 11, 2026 to shareholders of record on February 28, 2026.

Key Details

• NCIB Authorization: TSX approval; effective 19‑Feb‑2026; termination earliest of 18‑Feb‑2027 or completion of permitted purchases.
• Maximum Shares for Repurchase: Up to 2,258,992 common shares (10 % of public float).
• Public Float: 22,589,922 shares outstanding as of 5‑Feb‑2026.
• Average Daily Trading Volume (ADTV): 66,437 shares (Aug 2025 – Jan 2026).
• Daily Purchase Limit: 16,609 shares (25 % of ADTV).
• Purchase Method: Open‑market purchases via TSX and/or alternative Canadian trading systems at prevailing market price.
• Previous NCIB (Nov 28 2024 – Nov 27 2025): Authorized up to 2,258,532 shares; 19,100 shares purchased at a weighted average price of $9.17 per share.
• Automatic Repurchase Plan (ASPP): Agreement with designated broker for purchases during pre‑determined blackout periods; otherwise repurchases subject to management discretion and applicable law.
• Dividend Declaration: $0.01 per common share, record date 28 Feb 2026, payable 11 Mar 2026; treated as eligible dividends under the Canadian Income Tax Act.

Notable Quotes

(No direct quotes were provided in the release.)